INMD Stock Analysis: Buy, Sell, or Hold?
INMD - InMode Ltd. Ordinary Shares
$15.14
0.04 (0.30%)
▲
5d:
-0.2%
30d:
+3.13%
90d:
+4.63%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 05, 2026
2d
Get Alerted When INMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: INMD shows positive signals but monitor for confirmation. Market pricing in 4.2% growth. Moderate conviction.
💡 BUY OPPORTUNITY: INMD shows positive signals but monitor for confirmation. Market pricing in 4.2% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$18.45
Based on 6.8% avg growth
INTRINSIC VALUE TODAY
$11.46
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INMD is currently trading at $15.14, which is considered fair relative to its 30-day fair value range of $14.34 to $15.45. From a valuation perspective, the stock is trading at a premium (Forward PE: 10.5) compared to its historical average (9.2). At these levels, the market is pricing in 4.2% annual earnings growth.
Technical Outlook: Technically, INMD is in a uptrend. The price is currently testing key support at $14.94. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, INMD is in a uptrend. The price is currently testing key support at $14.94. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$14.34 -
$15.45
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
71.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($15.33)
- BULLISH: Expecting earnings turnaround to 4.2% growth with 5.3% revenue growth
Trading Range Analysis
30-Day Trading Range
$14.34 -
$15.45
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$14.94
Resistance Level
$15.60
Current Trend
Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.46
Wall Street Target
$15.33
(+1.3%)
Revenue Growth (YoY)
5.3%
Earnings Growth (YoY)
-30.8%
Profit Margin
23.3%
Valuation Premium vs History
+4.2% premium
PE vs Historical
10.5 vs 9.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.2%
(market-implied from PE analysis)
1-Year Target
$15.78
(+4%)
2-Year Target
$16.44
(+9%)
3-Year Target
$17.13
(+13%)
3-Yr Target (if PE normalizes)
(PE: 10→9)
PE COMPRESSION
$15.07
(-1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 9.5%)
$39.44
(+161%)
Base:
(SPY PE: 10.5, Growth: 9.5%)
$19.89
(+31%)
Bear:
(PE: 8.9, Growth: 9.5%)
$16.91
(+12%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (11x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 11.26 | Current EPS (TTM): $1.34
Bull Case
$17.94
(+19%)
Analyst growth 8.1%, PE expands to 12.4
Base Case
$16.31
(+8%)
Market implied 8.1%, PE stable at 11.3
Bear Case
$10.26
(-32%)
Severe decline -20.0%, PE contracts to 9.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 02, 2026 2:47 PM ET
Data refreshes hourly during market hours. Next update: 3:47 PM
Data refreshes hourly during market hours. Next update: 3:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 51 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 52 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 52 HOLD |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$99 | 60 HOLD |
Advanced INMD Option Strategies
Professional options setups generated by AI based on today's INMD price and gamma walls.
